Charles Schwab Investment Management Inc. Sells 517 Shares of Encompass Health Co. (NYSE:EHC)

Charles Schwab Investment Management Inc. trimmed its position in Encompass Health Co. (NYSE:EHC) by 0.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 640,419 shares of the company’s stock after selling 517 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.64% of Encompass Health worth $61,890,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Virtu Financial LLC bought a new position in shares of Encompass Health in the first quarter worth about $208,000. Cetera Advisors LLC acquired a new stake in Encompass Health in the first quarter valued at approximately $291,000. GAMMA Investing LLC grew its stake in shares of Encompass Health by 92.2% during the second quarter. GAMMA Investing LLC now owns 1,184 shares of the company’s stock worth $102,000 after buying an additional 568 shares during the last quarter. Harbor Capital Advisors Inc. increased its holdings in shares of Encompass Health by 275.7% during the second quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company’s stock worth $3,071,000 after buying an additional 26,270 shares in the last quarter. Finally, CWM LLC boosted its holdings in shares of Encompass Health by 6.3% during the 2nd quarter. CWM LLC now owns 6,388 shares of the company’s stock valued at $548,000 after acquiring an additional 379 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Encompass Health Trading Up 0.1 %

Shares of EHC stock opened at $102.98 on Friday. Encompass Health Co. has a 52-week low of $63.78 and a 52-week high of $104.55. The business’s fifty day moving average is $98.16 and its 200 day moving average is $91.39. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The company has a market capitalization of $10.38 billion, a PE ratio of 24.87, a price-to-earnings-growth ratio of 1.36 and a beta of 0.88.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.09. The firm had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter last year, the company posted $0.86 EPS. On average, equities research analysts anticipate that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s payout ratio is 16.43%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on EHC shares. Barclays increased their price objective on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Truist Financial reiterated a “buy” rating and issued a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Stephens reissued an “overweight” rating and set a $105.00 target price on shares of Encompass Health in a research note on Tuesday, August 6th. KeyCorp raised their price target on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, UBS Group upped their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Nine equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $107.11.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.